Ignite Creation Date:
2025-12-24 @ 10:57 PM
Ignite Modification Date:
2026-02-22 @ 12:23 PM
Study NCT ID:
NCT04023669
Status:
COMPLETED
Last Update Posted:
2025-02-07
First Post:
2019-07-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors
Sponsor:
St. Jude Children's Research Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-08
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-13
Completion Date Type:
ACTUAL
First Submit Date:
2019-07-11
First Submit QC Date:
None
Study First Post Date:
2019-07-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-06
Last Update Post Date:
2025-02-07
Last Update Post Date Type:
ACTUAL